Literature DB >> 30320483

Plasmapheresis for hypertriglyceridemia: The association between blood viscosity and triglyceride clearance rate.

Hung-Chieh Wu1,2, Lin-Chien Lee3, Wei-Jie Wang1,4.   

Abstract

OBJECTIVES: Several factors in double filtration plasmapheresis (DFPP) were associated with triglyceride (TG) clearance rate. This study examines whether baseline whole blood viscosity was a predictor for efficient TG removal.
METHODS: Adult subjects who receiving DFPP for hyperlipidemia in Taoyuan General Hospital from January 2015 to March 2018 were classified into efficient and inefficient TG removal according to TG removal rate ≥50% vs <50%. TG removal rate was defined as following formula: (pre-apheresis TG- post-apheresis TG)/pre-apheresis TG. Whole blood viscosity (WBV) was estimated by following equation: WBV = 0.12 × hematocrit +0.17 × (total protein -2.07). Univariate linear regression was used to assess the association between TG removal rate and WBV. Odds ratios (ORs) and 95% confidence interval (95%CI) for associations between variables and efficient TG removal were evaluated by logistic regression model to including univariate and multivariate adjustment.
RESULTS: From a total of 66 subjects receiving DFPP, 37 subjects reached efficient TG removal. The difference in pre-apheresis TG levels, hematocrit, and WBV between efficient vs. inefficient TG removal groups was 4.1 vs 6.7 mmol/L; 43.1% vs 39.5%; and 6.0cP vs 5.cP (Ps <0.05). After multivariate adjustment, WBC was a significant predictor for efficient TG removal (ORs and 95% CI were 3.192 (1.300-7.838), P < 0.05). The correlation between WBV and extraction of TG was significant (r = -0.255, P = 0.039).
CONCLUSION: Hyperviscosity reduced the efficiency of TG removal in those receiving DFPP.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  double filtration plasmapheresis; hematocrit; removal rate; triglyceride; viscosity

Mesh:

Substances:

Year:  2018        PMID: 30320483      PMCID: PMC6818594          DOI: 10.1002/jcla.22688

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  30 in total

1.  Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.

Authors:  Zbigniew M Szczepiorkowski; Jeffrey L Winters; Nicholas Bandarenko; Haewon C Kim; Michael L Linenberger; Marisa B Marques; Ravindra Sarode; Joseph Schwartz; Robert Weinstein; Beth H Shaz
Journal:  J Clin Apher       Date:  2010       Impact factor: 2.821

Review 2.  Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugs.

Authors:  Claudia Stefanutti; Ulrich Julius; Gerald F Watts; Mariko Harada-Shiba; Maria Cossu; Volker J Schettler; Giustina De Silvestro; Handrean Soran; Jeanine Roeters Van Lennep; Livia Pisciotta; Hans U Klör; Kurt Widhalm; Patrick M Moriarty
Journal:  J Clin Lipidol       Date:  2017-04-25       Impact factor: 4.766

3.  Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis.

Authors:  Vassilios G Athyros; Olga I Giouleme; Nikolaos L Nikolaidis; Themistoklis V Vasiliadis; Vassilios I Bouloukos; Athanasios G Kontopoulos; Nikolaos P Eugenidis
Journal:  J Clin Gastroenterol       Date:  2002-04       Impact factor: 3.062

4.  Efficacy of lipid apheresis: definitions and influencing factors.

Authors:  T Bosch; D Seidel; H J Gurland
Journal:  Int J Artif Organs       Date:  1995-04       Impact factor: 1.595

Review 5.  Hypertriglyceridemia and risk of coronary heart disease.

Authors:  John E Hokanson
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

6.  Evaluation of double filtration plasmapheresis, thermofiltration, and low-density lipoprotein adsorptive methods by crossover test in the treatment of familial hypercholesterolemia patients.

Authors:  M Suzuki; S Yamane; T Matsugane; T Nobuto; N Azuma; T Nishide; M Shinomiya; K Saito; N Sasaki; Y Nosé
Journal:  Artif Organs       Date:  1996-04       Impact factor: 3.094

7.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.

Authors:  Paul S Jellinger; Yehuda Handelsman; Paul D Rosenblit; Zachary T Bloomgarden; Vivian A Fonseca; Alan J Garber; George Grunberger; Chris K Guerin; David S H Bell; Jeffrey I Mechanick; Rachel Pessah-Pollack; Kathleen Wyne; Donald Smith; Eliot A Brinton; Sergio Fazio; Michael Davidson
Journal:  Endocr Pract       Date:  2017-04       Impact factor: 3.443

Review 8.  Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.

Authors:  Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Frank Sacks; Mohammad Hassan Murad; Anton F H Stalenhoef
Journal:  J Clin Endocrinol Metab       Date:  2012-09       Impact factor: 5.958

9.  Rosuvastatin Reduces Blood Viscosity in Patients with Acute Coronary Syndrome.

Authors:  Lae-Young Jung; Sang-Rok Lee; Jin-Mu Jung; Yi-Shik Kim; Sun-Hwa Lee; Kyoung-Suk Rhee; Jei-Keon Chae; Dong-Hwan Lee; Dal-Sik Kim; Won-Ho Kim; Jae-Ki Ko
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

10.  Lipid apheresis techniques: current status in Germany.

Authors:  Peter Grützmacher; Claudius Kleinert
Journal:  Clin Res Cardiol Suppl       Date:  2012-06
View more
  1 in total

1.  The Synergistic Effects of Astragalus mongholicus and Salvia miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment.

Authors:  Yun Zhang; Jie Wang; Yong-Mei Liu; Yin-Ying Chen; Xiao-Chen Yang; Lian Duan
Journal:  Drug Des Devel Ther       Date:  2021-09-27       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.